CYTEK BIOSCIENCES, INC. Increase (Decrease) in Prepaid Expense and Other Assets
CYTEK BIOSCIENCES, INC. (CTKB) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$1.60 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-05
- CYTEK BIOSCIENCES, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $2.25M, a 732.96% increase year-over-year.
- CYTEK BIOSCIENCES, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$3.85M, a 2685.91% decline year-over-year.
- CYTEK BIOSCIENCES, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $3.35M, a 351.89% increase year-over-year.
- CYTEK BIOSCIENCES, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$1.11M, a 142.68% decline year-over-year.
- CYTEK BIOSCIENCES, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $2.66M, a 5.38% decline from fiscal 2024.
- CYTEK BIOSCIENCES, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $2.81M, a 70.48% decline from fiscal 2023.
- CYTEK BIOSCIENCES, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $9.52M, a 50.86% decline from fiscal 2022.
- CYTEK BIOSCIENCES, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $19.36M, a 209.69% increase from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$1.60M 10-Q · filed 2026-08-05 | $1.75M derived: sum of 3 quarters · filed 2026-08-05 | $635.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$3.85M 10-Q · filed 2026-05-07 | -$500.00K derived: sum of 2 quarters · filed 2026-05-07 | -$1.61M derived: sum of 3 quarters · filed 2026-05-07 | -$1.34M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $3.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.24M derived: sum of 2 quarters · filed 2026-02-26 | $2.51M derived: sum of 3 quarters · filed 2026-08-05 | $2.66M 10-K · filed 2026-02-26 |
| 2025-09-30 | -$1.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$844.00K derived: sum of 2 quarters · filed 2026-08-05 | -$695.00K 10-Q · filed 2025-11-05 | $47.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $270.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $419.00K 10-Q · filed 2026-08-05 | $1.16M derived: sum of 3 quarters · filed 2026-08-05 | $3.77M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $149.00K 10-Q · filed 2026-05-07 | $891.00K derived: sum of 2 quarters · filed 2026-05-07 | $3.50M derived: sum of 3 quarters · filed 2026-05-07 | $33.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $742.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.35M derived: sum of 2 quarters · filed 2026-02-26 | -$116.00K derived: sum of 3 quarters · filed 2026-02-26 | $2.81M 10-K · filed 2026-02-26 |
| 2024-09-30 | $2.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$858.00K derived: sum of 2 quarters · filed 2025-11-05 | $2.07M 10-Q · filed 2025-11-05 | $9.25M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$3.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$543.00K 10-Q · filed 2025-08-06 | $6.64M derived: sum of 3 quarters · filed 2026-02-26 | $5.80M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $2.92M 10-Q · filed 2025-05-08 | $10.10M derived: sum of 2 quarters · filed 2026-02-26 | $9.27M derived: sum of 3 quarters · filed 2026-02-26 | $12.30M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $7.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $6.35M derived: sum of 2 quarters · filed 2026-02-26 | $9.38M derived: sum of 3 quarters · filed 2026-02-26 | $9.52M 10-K · filed 2026-02-26 |
| 2023-09-30 | -$833.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $2.20M derived: sum of 2 quarters · filed 2024-11-07 | $2.34M 10-Q · filed 2024-11-07 | $6.66M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $3.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $3.17M 10-Q · filed 2024-08-06 | $7.50M derived: sum of 3 quarters · filed 2025-02-28 | $13.87M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $136.00K 10-Q · filed 2024-05-08 | $4.46M derived: sum of 2 quarters · filed 2025-02-28 | $10.83M derived: sum of 3 quarters · filed 2025-02-28 | $15.15M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $4.33M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $10.70M derived: sum of 2 quarters · filed 2025-02-28 | $15.01M derived: sum of 3 quarters · filed 2025-02-28 | $19.36M 10-K · filed 2025-02-28 |
| 2022-09-30 | $6.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $10.68M derived: sum of 2 quarters · filed 2023-11-14 | $15.04M 10-Q · filed 2023-11-14 | $16.29M derived: sum of 4 quarters · filed 2024-03-13 |
| 2022-06-30 | $4.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $8.66M 10-Q · filed 2023-08-08 | $9.91M derived: sum of 3 quarters · filed 2024-03-13 | $12.36M derived: sum of 4 quarters · filed 2024-03-13 |
| 2022-03-31 | $4.35M 10-Q · filed 2023-05-09 | $5.60M derived: sum of 2 quarters · filed 2024-03-13 | $8.05M derived: sum of 3 quarters · filed 2024-03-13 | $10.13M derived: sum of 4 quarters · filed 2024-03-13 |
| 2021-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $3.69M derived: sum of 2 quarters · filed 2024-03-13 | $5.78M derived: sum of 3 quarters · filed 2024-03-13 | $6.25M 10-K · filed 2024-03-13 |
| 2021-09-30 | $2.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $4.53M derived: sum of 2 quarters · filed 2022-11-09 | $5.00M 10-Q · filed 2022-11-09 | $4.24M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $2.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $2.56M 10-Q · filed 2022-08-10 | $1.79M derived: sum of 3 quarters · filed 2023-03-01 | $2.39M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $477.00K 10-Q · filed 2022-05-12 | -$287.00K derived: sum of 2 quarters · filed 2023-03-01 | $313.00K derived: sum of 3 quarters · filed 2023-03-01 | |
| 2020-12-31 | -$764.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$164.00K derived: sum of 2 quarters · filed 2023-03-01 | $8.22M 10-K · filed 2023-03-01 | |
| 2020-09-30 | $600.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $8.98M 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $8.38M 10-Q · filed 2021-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |